BACKGROUND: To explore the efficacy of @entity2857 in treating @entity157 ( @entity157 ) and its relationship with the computed tomography (CT) and magnetic resonance imaging (MRI) features of @entity157 , analyze the prognostic factors of @entity157 @entity1 treated with @entity2857 , and investigate the relationship between imaging findings and outcomes. METHODS: A total of 38 @entity157 @entity1 who were treated with @entity2857 from April 2009 to December 2010 were included in this study. HCCs were classified as good arterial supply and poor arterial supply according to the intensity enhancement on CT scan or MRI. Clinical data were collected and the survival time was calculated by Kaplan-Meier method. RESULTS: Among these 38 @entity1 [35 (92.1%) were males] treated with @entity2857 , the median age was (53.3  11.1) years. @entity5 in 17 @entity1 had good arterial supply while those in the remained 21 @entity1 had poor arterial supply. The @entity1349 ( @entity1349 ) was 10.7 months (95% CI, 8.7-12.7) and the 1-year @entity1349 ( @entity1349 ) was 41.0%. The @entity1349 and 1-year @entity1349 in @entity1 with @entity5 with good arterial supply were 12 months (range, 4-20 months) and 52.9%, respectively, compared with those of 7 months (range, 1-16 months) and 23.8% in @entity1 with @entity5 with poor arterial supply (P=0.002). @entity1 with BCLC stage B @entity5 had longer @entity1349 and higher @entity1349 than those with BCLC stage C @entity5 , although the differences were not statistically significant. Multivariate analysis showed that arterial supply of @entity5 remained statistically predictive for @entity1349 (HR =0.22; 95% CI, 0.07-0.67; P=0.008). CONCLUSIONS: Arterial blood supply is an independent predictor for survival in @entity157 @entity1 treated with @entity2857 , and @entity1 with @entity5 with good arterial supply benefit more than those with @entity5 with poor arterial supply.

Arterial blood supply of XXXX is associated with efficacy of @entity2857 therapy.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['Tumors', 'tumors'] @entity2857 :: ('MESH:C471405', 'Chemical') :: ['sorafenib'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'hepatocellular carcinoma'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'overall survival', 'median survival time', 'MST']
@entity157 :: (MESH:D006528,Disease) :: ['hepatocellular carcinoma']
